HomeHeadlinesEli Lilly agreed to acquire three vaccine developers, Curevo, LimmaTech and Vaccine Co, for nearly USD 4bln, WSJ reportsMAY 26, 2026 AT 10:35 AMEli Lilly agreed to acquire three vaccine developers, Curevo, LimmaTech and Vaccine Co, for nearly USD 4bln, WSJ reportsByNewsquawk StaffImportanceLevel 1#EU SESSION#US EQUITIES
MAY 26, 2026 AT 10:35 AMEli Lilly agreed to acquire three vaccine developers, Curevo, LimmaTech and Vaccine Co, for nearly USD 4bln, WSJ reportsByNewsquawk StaffImportanceLevel 1#EU SESSION#US EQUITIES
